A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats

The Brain Metabolite Kynurenic Acid Inhibits α7 Nicotinic Receptor Activity and Increases Non-α7 Nicotinic Receptor Expression: Physiopathological Implications

Corey J. Hilmas, Edna F. R. Pereira, Manickavasagom Alkondon et al. · Journal of Neuroscience · 2001 · 853 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Increased cortical kynurenate content in schizophrenia

Robert Schwarcz, Arash Rassoulpour, Hui‐Qiu Wu et al. · Biological Psychiatry · 2001 · 584 citations

Medicine, Neurobiology, Neuroscience +9

Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia

Klas R. Linderholm, Elisabeth Skogh, Sara K. Olsson et al. · Schizophrenia Bulletin · 2010 · 315 citations · Full text

Life Sciences, Neuroscience, Pharmacology +13

Nicotine Induces Glutamate Release from Thalamocortical Terminals in Prefrontal Cortex

Evelyn K. Lambe, Marina R. Picciotto, George K. Aghajanian · Neuropsychopharmacology · 2003 · 266 citations

Life Sciences, Neurobiology, Neuroscience +16

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia

L.K. Nilsson, K.R. Linderholm, Göran Engberg et al. · Schizophrenia Research · 2005 · 235 citations

Medicine, Neuroscience, Psychiatry +7